TearScience releases LipiScan for rapid HD meibomian imaging
Morrisville, NCâTearScience has released LipiScan, the first dedicated high definition (HD) gland imager that allows eyecare professionals (ECPs) to efficiently evaluate meibomian glands.
The new rapid imager was created with end users in mind. LipiScan incorporates patented dynamic meibomian imaging (DMI) technology to produce HD images of meibomian glands. LipiScan allows ECPs to assess meibomian gland structure during routine workups in any practice setting.
I-MED Pharma introduces new tear osmolarity device
MontrealâI-MED Pharma has launched i-Pen, a hand
-held device designed for a measurement of tear osmolarity.
I-MED Pharma Vice President Daniel Hofmann estimates that the companyâs business model will allow clinicians to recover their capital costs with fewer than 40 patients.
He anticipates that the i-Pen will be submitted to U.S. Food and Drug Administration (FDA) in 2016 and that it will not require a CLIA waiver.